All investors

Forbion

Naarden, Netherlands

Venture capitalSeedSeries ASeries BGrowth
Ticket size
Not published
Activity
Last deal November 2026
Visit website

About

Global venture capital firm investing in biotech and sustainable solutions for human and planetary health; EUR 7.5bn across 13 funds.

Headquarters
Naarden, Netherlands
Invests in
Europe

Last checked 19 November 2026

Industries

  • Biotech

Latest deal

November 2026

News releases on portfolio milestones (Enterprise Therapeutics EMA designation, Noema Pharma FDA designation)

Source

Work at Forbion? Claim this listing to keep it up to date.

Claim this fund

Something wrong or out of date? Tell us and we'll fix it.

Report a mistake

We list funds from public sources and check each one's website and recent activity. No guarantee of accuracy, and this is not investment advice.